(2R,3R)-6,8-Dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9-(4-hydroxyphenyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-h]chromen-7-one(CAS: 86831-53-0)

The compound is subject to the REACH regulations in the EU, which require registration for substances above one tonne per year. It also falls under the purview of the GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labeling. In the US, the FDA may regulate its use in pharmaceutical applications, and the EPA may oversee environmental impacts. Local regulations should also be considered.

Common alternatives in synthesis include isomers such as (2S,3S)-6,8-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9-(4-hydroxyphenyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-h]chromen-7-one or related compounds like 6,8-dihydroxy-3-(4-hydroxyphenyl)-2-(hydroxymethyl)-9-(4-hydroxyphenyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-h]chromen-7-one. Substitutes may also include various dioxin derivatives with similar functional groups.

The compound is increasingly being explored for its biological activities, particularly in the fields of cancer research and inflammation. Market trends indicate growing interest in natural product chemistry and bioactive compounds. Recent research focuses on its potential as a drug candidate and its role in cellular signaling pathways.

Waste containing this compound should be collected in appropriate containers and managed in accordance with local regulations. It is advisable to incinerate the waste in a professional facility or use chemically safe disposal methods. Environmental protection should be a priority, and precautions should be taken to prevent soil and water contamination. Safe waste disposal practices are essential to ensure minimal environmental impact.